About this trial
The goal of this clinical trial is to test the cooling effect of cooling blanket in patients with heat stroke. The main questions it aims to answer are:
* the cooling rate of cooling blanket in patients with heat stroke * the relationship between cooling blanket and outcomes in patients with heat stroke
Participants will accept the cooling blanket or non-cooling blanket according to the randomization group.
Researchers will compare cooling rate and outcomes to see if the cooling blanket can accelerate the cooling speed and improve the prognosis of patients in heat stroke.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥ 18 years old
diagnosed as heat stroke
informed consent of patients or family members
Disqualifiers
need immediate cardiopulmonary resuscitation
body temperature <39.5℃ on admission
with the underlying disease of severe organ damage
pregnant women
Trial design
Parallel
Treatments tested in this trial
cooling blanket
DeviceOn the basis of the cooling methods of non-cooling blanket group, combine the cooling blanket to cool down. The cooling blanket is required to be activated within 30min after admission. The blanket temperature will be set at 4-10℃, and the target body temperature is 38℃.
non-cooling blanket
DevicePatients do not receive cooling blanket according to randomization. Cooling body temperature by: control the temperature of the emergency room to 20-24℃, 4℃ fluid infusion, ice packs, evaporation, convection,etc.
Treatment groups
Trial outcomes
Primary outcomes
0.5-hour temperature reduction
Calculated as the difference between initial core temperature and core temperature at 0.5 hours after admission.
Body temperature of 0.5 hours
Body temperature of 0.5 hours referred to the temperature value obtained 5 min before and after 0.5 hour.
Secondary outcomes
Body temperature of 2 hours
Body temperature of 2 hours referred to the temperature value obtained 20 min before and after 2 hours.
incidence of organ damage
number of participants with organ damage, including but not limited to brain, lung, heart, kidney, liver, and coagulation function
length of ICU stay
The length patient stay at ICU
in-hospital mortality
number of participants dead in-hospital
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
Yiwu Central Hospital
Collaborator
Jinhua Municipal Central Hospital
Collaborator
Jinhua People's Hospital
Collaborator
Lanxi People's Hospital
Collaborator
Yongkang No.1 People' s Hospital
Collaborator
Dongyang People's Hospital
Collaborator